부산대학교 도서관

Wang Z; Photophysique et Photochimie Supramoléculaires et Macromoléculaires, Université Paris-Saclay, ENS Paris-Saclay, CNRS, Gif-sur-Yvette, France.; Rivero-Barbarroja G; Department of Organic Chemistry, Faculty of Chemistry, University of Seville, Seville, Spain.; Benito JM; Instituto de Investigaciones Químicas (IIQ), CSIC - Universidad de Sevilla, Seville, Spain.; Maisonneuve S; Photophysique et Photochimie Supramoléculaires et Macromoléculaires, Université Paris-Saclay, ENS Paris-Saclay, CNRS, Gif-sur-Yvette, France.; Vélaz I; Department of Chemistry, School of Sciences, University of Navarra, Pamplona, Spain.; Juárez-Gonzálvez I; Department of Pharmaceutical Sciences, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain.; Garrido MJ; Department of Pharmaceutical Sciences, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain.; Tros de Ilarduya C; Department of Pharmaceutical Sciences, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain.; Ortiz Mellet C; Department of Organic Chemistry, Faculty of Chemistry, University of Seville, Seville, Spain. mellet@us.es.; Xie J; Photophysique et Photochimie Supramoléculaires et Macromoléculaires, Université Paris-Saclay, ENS Paris-Saclay, CNRS, Gif-sur-Yvette, France. joanne.xie@ens-paris-saclay.fr.; García Fernández JM; Instituto de Investigaciones Químicas (IIQ), CSIC - Universidad de Sevilla, Seville, Spain. jogarcia@iiq.csic.es.

Publisher: Springer Nature Country of Publication: England NLM ID: 101725670 Publication Model: Electronic Cited Medium: Internet ISSN: 2399-3669 (Electronic) Linking ISSN: 23993669 NLM ISO Abbreviation: Commun Chem Subsets: PubMed not MEDLINE

Salgado-Pascual A; Department of Pharmaceutical Sciences, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain; Navarra Institute for Health Research (IdisNA), Pamplona, Spain.; Zalba S; Department of Pharmaceutical Sciences, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain; Navarra Institute for Health Research (IdisNA), Pamplona, Spain.; Lasarte JJ; Program of Immunology and Immunotherapy, CIMA, CCUN-University of Navarra, Pamplona, Spain; Navarra Institute for Health Research (IdisNA), Pamplona, Spain. Electronic address: jjlasarte@unav.es.; Garrido MJ; Department of Pharmaceutical Sciences, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain; Navarra Institute for Health Research (IdisNA), Pamplona, Spain. Electronic address: mgarrido@unav.es.

Publisher: Elsevier Science Publishers, B.V Country of Publication: Netherlands NLM ID: 8710523 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8294 (Electronic) Linking ISSN: 0169409X NLM ISO Abbreviation: Adv Drug Deliv Rev Subsets: MEDLINE

Arrizabalaga L; Program of Immunology and Immunotherapy, Cancer Center Clínica, Cima Universidad de Navarra, Universidad de Navarra (CCUN), Avenida Pio XII, 55, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Di Trani CA; Program of Immunology and Immunotherapy, Cancer Center Clínica, Cima Universidad de Navarra, Universidad de Navarra (CCUN), Avenida Pio XII, 55, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Fernández-Sendin M; Program of Immunology and Immunotherapy, Cancer Center Clínica, Cima Universidad de Navarra, Universidad de Navarra (CCUN), Avenida Pio XII, 55, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Bella Á; Program of Immunology and Immunotherapy, Cancer Center Clínica, Cima Universidad de Navarra, Universidad de Navarra (CCUN), Avenida Pio XII, 55, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Russo-Cabrera JS; Program of Immunology and Immunotherapy, Cancer Center Clínica, Cima Universidad de Navarra, Universidad de Navarra (CCUN), Avenida Pio XII, 55, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Gomar C; Program of Immunology and Immunotherapy, Cancer Center Clínica, Cima Universidad de Navarra, Universidad de Navarra (CCUN), Avenida Pio XII, 55, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Ardaiz N; Program of Immunology and Immunotherapy, Cancer Center Clínica, Cima Universidad de Navarra, Universidad de Navarra (CCUN), Avenida Pio XII, 55, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Belsue V; Program of Immunology and Immunotherapy, Cancer Center Clínica, Cima Universidad de Navarra, Universidad de Navarra (CCUN), Avenida Pio XII, 55, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; González-Gomariz J; Program of Immunology and Immunotherapy, Cancer Center Clínica, Cima Universidad de Navarra, Universidad de Navarra (CCUN), Avenida Pio XII, 55, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Zalba S; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Department of Pharmaceutical Sciences, School of Pharmacy & Nutrition, University of Navarra, Pamplona, Spain.; Gil-Korilis A; Program of Immunology and Immunotherapy, Cancer Center Clínica, Cima Universidad de Navarra, Universidad de Navarra (CCUN), Avenida Pio XII, 55, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Garrido MJ; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Department of Pharmaceutical Sciences, School of Pharmacy & Nutrition, University of Navarra, Pamplona, Spain.; Melero I; Program of Immunology and Immunotherapy, Cancer Center Clínica, Cima Universidad de Navarra, Universidad de Navarra (CCUN), Avenida Pio XII, 55, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Spanish Center for Biomedical Research Network in Oncology (CIBERONC), Madrid, Spain.; Department of Oncology, Cancer Center Clínica, Universidad de Navarra (CCUN), Madrid, Spain.; Nuffield Department of Medicine (NDM), University of Oxford, Oxford, UK.; Aranda F; Program of Immunology and Immunotherapy, Cancer Center Clínica, Cima Universidad de Navarra, Universidad de Navarra (CCUN), Avenida Pio XII, 55, Pamplona, Spain. faranda@unav.es.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain. faranda@unav.es.; Berraondo P; Program of Immunology and Immunotherapy, Cancer Center Clínica, Cima Universidad de Navarra, Universidad de Navarra (CCUN), Avenida Pio XII, 55, Pamplona, Spain. pberraondol@unav.es.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain. pberraondol@unav.es.; Spanish Center for Biomedical Research Network in Oncology (CIBERONC), Madrid, Spain. pberraondol@unav.es.

Publisher: BioMed Central Country of Publication: England NLM ID: 101152208 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-3155 (Electronic) Linking ISSN: 14773155 NLM ISO Abbreviation: J Nanobiotechnology Subsets: MEDLINE

Ezcurra-Hualde M; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Zalba S; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Department of Pharmaceutical Sciences, School of Pharmacy & Nutrition, University of Navarra, Pamplona, Spain.; Bella Á; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Arrizabalaga L; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Risson A; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; García-Fuentes R; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Gomar C; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Ardaiz N; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Belsue V; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Ruiz-Guillamon D; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Serrano-Alcaide A; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Department of Pharmaceutical Sciences, School of Pharmacy & Nutrition, University of Navarra, Pamplona, Spain.; Salgado A; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Department of Pharmaceutical Sciences, School of Pharmacy & Nutrition, University of Navarra, Pamplona, Spain.; Aranda F; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Garrido MJ; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Department of Pharmaceutical Sciences, School of Pharmacy & Nutrition, University of Navarra, Pamplona, Spain.; Berraondo P; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Spanish Center for Biomedical Research Network in Oncology (CIBERONC), Madrid, Spain.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Garrido, Marı́a J; Trocóniz, Iñaki F

In Journal of Pharmacological and Toxicological Methods 1999 42(2):61-66

Cheng Z; Precision Medicine in Oncology (PrMiO), Department of Pathology, Erasmus MC Cancer Institute, Erasmus Medical Center, Rotterdam, The Netherlands.; Nanomedicine Innovation Center Erasmus (NICE), Erasmus Medical Center, Rotterdam, The Netherlands.; Fobian SF; Precision Medicine in Oncology (PrMiO), Department of Pathology, Erasmus MC Cancer Institute, Erasmus Medical Center, Rotterdam, The Netherlands.; Nanomedicine Innovation Center Erasmus (NICE), Erasmus Medical Center, Rotterdam, The Netherlands.; Gurrieri E; Laboratory of Biotechnology and Nanomedicine, Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.; Amin M; Precision Medicine in Oncology (PrMiO), Department of Pathology, Erasmus MC Cancer Institute, Erasmus Medical Center, Rotterdam, The Netherlands.; Nanomedicine Innovation Center Erasmus (NICE), Erasmus Medical Center, Rotterdam, The Netherlands.; D'Agostino VG; Laboratory of Biotechnology and Nanomedicine, Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.; Falahati M; Precision Medicine in Oncology (PrMiO), Department of Pathology, Erasmus MC Cancer Institute, Erasmus Medical Center, Rotterdam, The Netherlands.; Zalba S; Department of Pharmaceutical Sciences, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain.; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Navarra Institute for Health Research, Pamplona, Spain.; Debets R; Laboratory of Tumor Immunology, Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus Medical Center, Rotterdam, The Netherlands.; Garrido MJ; Department of Pharmaceutical Sciences, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain.; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Navarra Institute for Health Research, Pamplona, Spain.; Saeed M; Precision Medicine in Oncology (PrMiO), Department of Pathology, Erasmus MC Cancer Institute, Erasmus Medical Center, Rotterdam, The Netherlands.; Seynhaeve ALB; Precision Medicine in Oncology (PrMiO), Department of Pathology, Erasmus MC Cancer Institute, Erasmus Medical Center, Rotterdam, The Netherlands.; Balcioglu HE; Laboratory of Tumor Immunology, Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus Medical Center, Rotterdam, The Netherlands. h.balcioglu@erasmusmc.nl.; Ten Hagen TLM; Precision Medicine in Oncology (PrMiO), Department of Pathology, Erasmus MC Cancer Institute, Erasmus Medical Center, Rotterdam, The Netherlands. t.l.m.tenhagen@erasmusmc.nl.; Nanomedicine Innovation Center Erasmus (NICE), Erasmus Medical Center, Rotterdam, The Netherlands. t.l.m.tenhagen@erasmusmc.nl.

Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722 (Electronic) Linking ISSN: 17568722 NLM ISO Abbreviation: J Hematol Oncol Subsets: MEDLINE

Merino, María, PhD; Contreras, Ana, PhD; Casares, Noelia, PhD; Troconiz, Iñaki F., PhD; ten Hagen, Timo LM, PhD; Berraondo, Pedro, PhD; Zalba, Sara, PhD; Garrido, María J, PhD

Nanomedicine: Nanotechnology, Biology, and Medicine. 17:13-25

Parra-Guillen ZP; Department of Pharmaceutical Technology and Chemistry, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.; Sancho-Araiz A; Department of Pharmaceutical Technology and Chemistry, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.; Mayawala K; Quantitative Pharmacology and Pharmacometrics Immune/Oncology (QP2-I/O), Merck & Co., Inc., Rahway, New Jersey, USA.; Zalba S; Department of Pharmaceutical Technology and Chemistry, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.; Garrido MJ; Department of Pharmaceutical Technology and Chemistry, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.; de Alwis D; Quantitative Pharmacology and Pharmacometrics Immune/Oncology (QP2-I/O), Merck & Co., Inc., Rahway, New Jersey, USA.; Troconiz IF; Department of Pharmaceutical Technology and Chemistry, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.; Freshwater T; Quantitative Pharmacology and Pharmacometrics Immune/Oncology (QP2-I/O), Merck & Co., Inc., Rahway, New Jersey, USA.

Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE

Rivero-Barbarroja G; Department of Organic Chemistry, Faculty of Chemistry, University of Seville, 41012 Sevilla, Spain.; López-Fernández J; Instituto de Investigaciones Químicas (IIQ), CSIC - Universidad de Sevilla, 41092 Sevilla, Spain.; Juárez-Gonzálvez I; Department of Pharmaceutical Sciences, School of Pharmacy and Nutrition, University of Navarra, 31080 Pamplona, Spain.; Fernández-Clavero C; Departamento de Química Analítica, Química Física e Ingeniería Química and Instituto de Investigación Química 'Andrés del Rio', Universidad de Alcalá, Spain.; Di Giorgio C; Institut de Chimie Nice, UMR 7272, Université Côte d'Azur, F-06108 Nice, France.; Vélaz I; Department of Chemistry, School of Sciences, University of Navarra, 31080 Pamplona, Spain.; Garrido MJ; Department of Pharmaceutical Sciences, School of Pharmacy and Nutrition, University of Navarra, 31080 Pamplona, Spain.; Benito JM; Instituto de Investigaciones Químicas (IIQ), CSIC - Universidad de Sevilla, 41092 Sevilla, Spain.; Ortiz Mellet C; Department of Organic Chemistry, Faculty of Chemistry, University of Seville, 41012 Sevilla, Spain. Electronic address: mellet@us.es.; Mendicuti F; Departamento de Química Analítica, Química Física e Ingeniería Química and Instituto de Investigación Química 'Andrés del Rio', Universidad de Alcalá, Spain. Electronic address: francisco.mendicuti@uah.es.; Tros de Ilarduya C; Department of Pharmaceutical Sciences, School of Pharmacy and Nutrition, University of Navarra, 31080 Pamplona, Spain. Electronic address: ctros@unav.es.; García Fernández JM; Instituto de Investigaciones Químicas (IIQ), CSIC - Universidad de Sevilla, 41092 Sevilla, Spain. Electronic address: jogarcia@iiq.csic.es.

Publisher: Elsevier Applied Science Publishers Country of Publication: England NLM ID: 8307156 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-1344 (Electronic) Linking ISSN: 01448617 NLM ISO Abbreviation: Carbohydr Polym Subsets: MEDLINE

Serrano A; Department of Pharmaceutical Sciences, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IdisNA), Pamplona, Spain.; Casares N; Navarra Institute for Health Research (IdisNA), Pamplona, Spain.; Program of Immunology and Immunotherapy, CIMA, Pamplona, Spain.; Trocóniz IF; Department of Pharmaceutical Sciences, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IdisNA), Pamplona, Spain.; Lozano T; Navarra Institute for Health Research (IdisNA), Pamplona, Spain.; Program of Immunology and Immunotherapy, CIMA, Pamplona, Spain.; Lasarte JJ; Navarra Institute for Health Research (IdisNA), Pamplona, Spain.; Program of Immunology and Immunotherapy, CIMA, Pamplona, Spain.; Zalba S; Department of Pharmaceutical Sciences, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain. szalbaot@unav.es.; Navarra Institute for Health Research (IdisNA), Pamplona, Spain. szalbaot@unav.es.; Garrido MJ; Department of Pharmaceutical Sciences, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain. mgarrido@unav.es.; Navarra Institute for Health Research (IdisNA), Pamplona, Spain. mgarrido@unav.es.

Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 100956087 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1745-7254 (Electronic) Linking ISSN: 16714083 NLM ISO Abbreviation: Acta Pharmacol Sin Subsets: MEDLINE

Serrano A; Department of Pharmaceutical Sciences, School of Pharmacy and Nutrition, University of Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research (IdisNA), 31008 Pamplona, Spain.; Zalba S; Department of Pharmaceutical Sciences, School of Pharmacy and Nutrition, University of Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research (IdisNA), 31008 Pamplona, Spain.; Lasarte JJ; Navarra Institute for Health Research (IdisNA), 31008 Pamplona, Spain.; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain.; Troconiz IF; Department of Pharmaceutical Sciences, School of Pharmacy and Nutrition, University of Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research (IdisNA), 31008 Pamplona, Spain.; Institute of Data Sciences and Artificial Intelligence (DATAI), University of Navarra, 31008 Pamplona, Spain.; Riva N; Department of Pharmaceutical Sciences, School of Pharmacy and Nutrition, University of Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research (IdisNA), 31008 Pamplona, Spain.; Garrido MJ; Department of Pharmaceutical Sciences, School of Pharmacy and Nutrition, University of Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research (IdisNA), 31008 Pamplona, Spain.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101534003 Publication Model: Electronic Cited Medium: Print ISSN: 1999-4923 (Print) Linking ISSN: 19994923 NLM ISO Abbreviation: Pharmaceutics Subsets: PubMed not MEDLINE

Córdoba KM; Hepatology Program, Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), 31008 Pamplona, Spain.; Serrano-Mendioroz I; Hepatology Program, Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), 31008 Pamplona, Spain.; Jericó D; Hepatology Program, Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), 31008 Pamplona, Spain.; Merino M; Department of Pharmacy and Pharmaceutical Technology, School of Pharmacy, University of Navarra, 31008 Pamplona, Spain.; Jiang L; Moderna Inc., Cambridge, MA 02139, USA.; Sampedro A; Hepatology Program, Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), 31008 Pamplona, Spain.; Alegre M; Neurophysiology Laboratory, Neuroscience Area, CIMA and Clínica Universitaria, University of Navarra, 31008 Pamplona, Spain.; Corrales F; Proteomics Unit, Centro Nacional de Biotecnología (CSIC), 28049 Madrid, Spain.; Garrido MJ; Department of Pharmacy and Pharmaceutical Technology, School of Pharmacy, University of Navarra, 31008 Pamplona, Spain.; Martini PGV; Moderna Inc., Cambridge, MA 02139, USA.; Lanciego JL; Navarra Institute for Health Research (IDISNA), 31008 Pamplona, Spain.; Neurosciences Department, CIMA-University of Navarra, 31008 Pamplona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNed), Instituto de Salud Carlos III, 28031 Madrid, Spain.; Prieto J; Hepatology Program, Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain.; Berraondo P; Navarra Institute for Health Research (IDISNA), 31008 Pamplona, Spain.; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, 31008 Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Fontanellas A; Hepatology Program, Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), 31008 Pamplona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, 28029 Madrid, Spain.

Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE

Parra-Guillen ZP; Department of Pharmaceutical Technology and Chemistry, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.; Freshwater T; Merck & Co., Inc., Kenilworth, NJ, United States.; Cao Y; Merck & Co., Inc., Kenilworth, NJ, United States.; Mayawala K; Merck & Co., Inc., Kenilworth, NJ, United States.; Zalba S; Department of Pharmaceutical Technology and Chemistry, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.; Garrido MJ; Department of Pharmaceutical Technology and Chemistry, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.; de Alwis D; Merck & Co., Inc., Kenilworth, NJ, United States.; Troconiz IF; Department of Pharmaceutical Technology and Chemistry, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.

Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE

Merino M; Department of Pharmaceutical Technology and Chemistry, School of Pharmacy, University of Navarra, 31008, Pamplona, Navarra, Spain.; Lozano T; Program of Immunology and Immunotherapy, CIMA-Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IdisNA), Pamplona, Spain.; Casares N; Program of Immunology and Immunotherapy, CIMA-Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IdisNA), Pamplona, Spain.; Lana H; Department of Pharmaceutical Technology and Chemistry, School of Pharmacy, University of Navarra, 31008, Pamplona, Navarra, Spain.; Troconiz IF; Department of Pharmaceutical Technology and Chemistry, School of Pharmacy, University of Navarra, 31008, Pamplona, Navarra, Spain.; Navarra Institute for Health Research (IdisNA), Pamplona, Spain.; Ten Hagen TLM; Laboratory of Experimental Oncology, Erasmus Medical Center, Rotterdam, The Netherlands.; Kochan G; Navarra Institute for Health Research (IdisNA), Pamplona, Spain.; Department of Oncology, Navarrabiomed-Biomedical Research Centre, Pamplona, Spain.; Berraondo P; Program of Immunology and Immunotherapy, CIMA-Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IdisNA), Pamplona, Spain.; Zalba S; Department of Pharmaceutical Technology and Chemistry, School of Pharmacy, University of Navarra, 31008, Pamplona, Navarra, Spain. szalbaot@unav.es.; Navarra Institute for Health Research (IdisNA), Pamplona, Spain. szalbaot@unav.es.; Garrido MJ; Department of Pharmaceutical Technology and Chemistry, School of Pharmacy, University of Navarra, 31008, Pamplona, Navarra, Spain. mgarrido@unav.es.; Navarra Institute for Health Research (IdisNA), Pamplona, Spain. mgarrido@unav.es.

Publisher: BioMed Central Country of Publication: England NLM ID: 101152208 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-3155 (Electronic) Linking ISSN: 14773155 NLM ISO Abbreviation: J Nanobiotechnology Subsets: MEDLINE

Buñuales, María; Düzgünes, Nejat; Zalba, Sara; Garrido, María J; Tros de ILarduya, Conchita

Nanomedicine. January, 2011, Vol. 6 Issue 1, p89, 10 p.

Zalba, Sara; Contreras, Ana Margarita; Merino, María; Navarro, Iñigo; de Ilarduya, Conchita Tros; Trocóniz, Iñaki F; Koning, Gerben; Garrido, María J

Nanomedicine; Mar2016, Vol. 11 Issue 5, p465-477, 13p

Trocóniz, Iñaki F; Cendrós, Josep-María; Peraire, Concepción; Ramis, Joaquim; Garrido, Maria J; Boscani, Paolo F; Obach, Rosendo

Clinical Pharmacokinetics. Jan 01, 2009 48(1):51-62

Zalba S; Department of Pharmaceutical Technology and Chemistry, School of Pharmacy & Nutrition, University of Navarra; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.; Ten Hagen TLM; Laboratory of Experimental Oncology, and Nanomedicine Innovation Center Erasmus (NICE), Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands.; Burgui C; Department of Pharmaceutical Technology and Chemistry, School of Pharmacy & Nutrition, University of Navarra.; Garrido MJ; Department of Pharmaceutical Technology and Chemistry, School of Pharmacy & Nutrition, University of Navarra; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain. Electronic address: mgarrido@unav.es.

Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8607908 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4995 (Electronic) Linking ISSN: 01683659 NLM ISO Abbreviation: J Control Release Subsets: MEDLINE

Garrido, María J; Habre, Walid; Rombout, Ferdinand; Trocóniz, Iñaki F

Pharmaceutical Research, Vol. 23, No 9 (2006) pp. 2014-23

Navarro-Ocón A; GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, 18016 Granada, Spain.; Instituto de Investigación Biosanitaria (ibs.GRANADA), 18012 Granada, Spain.; Blaya-Cánovas JL; GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, 18016 Granada, Spain.; Instituto de Investigación Biosanitaria (ibs.GRANADA), 18012 Granada, Spain.; UGC de Oncología Médica, Complejo Hospitalario de Jaen, 23007 Jaen, Spain.; López-Tejada A; GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, 18016 Granada, Spain.; Instituto de Investigación Biosanitaria (ibs.GRANADA), 18012 Granada, Spain.; Department of Biochemistry and Molecular Biology 2, School of Pharmacy, University of Granada, 18011 Granada, Spain.; Blancas I; Instituto de Investigación Biosanitaria (ibs.GRANADA), 18012 Granada, Spain.; UGC de Oncología, Hospital Universitario 'San Cecilio', 18016 Granada, Spain.; Sánchez-Martín RM; GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, 18016 Granada, Spain.; Instituto de Investigación Biosanitaria (ibs.GRANADA), 18012 Granada, Spain.; Garrido MJ; Department of Pharmaceutical Technology and Chemistry, School of Pharmacy & Nutrition, Navarra Institute for Health Research (IdisNA), University of Navarra, 31080 Pamplona, Spain.; Griñán-Lisón C; GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, 18016 Granada, Spain.; Instituto de Investigación Biosanitaria (ibs.GRANADA), 18012 Granada, Spain.; UGC de Oncología Médica, Complejo Hospitalario de Jaen, 23007 Jaen, Spain.; Calahorra J; GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, 18016 Granada, Spain.; Instituto de Investigación Biosanitaria (ibs.GRANADA), 18012 Granada, Spain.; UGC de Oncología Médica, Complejo Hospitalario de Jaen, 23007 Jaen, Spain.; Cara FE; GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, 18016 Granada, Spain.; Instituto de Investigación Biosanitaria (ibs.GRANADA), 18012 Granada, Spain.; Ruiz-Cabello F; Instituto de Investigación Biosanitaria (ibs.GRANADA), 18012 Granada, Spain.; Department of Biochemistry, Molecular Biology 3 and Immunology, School of Medicine, University of Granada, 18071 Granada, Spain.; Marchal JA; Instituto de Investigación Biosanitaria (ibs.GRANADA), 18012 Granada, Spain.; Department of Human Anatomy and Embryology, School of Medicine, University of Granada, 18016 Granada, Spain.; Aptsiauri N; Instituto de Investigación Biosanitaria (ibs.GRANADA), 18012 Granada, Spain.; Department of Biochemistry, Molecular Biology 3 and Immunology, School of Medicine, University of Granada, 18071 Granada, Spain.; Granados-Principal S; GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, 18016 Granada, Spain.; Instituto de Investigación Biosanitaria (ibs.GRANADA), 18012 Granada, Spain.; Department of Biochemistry and Molecular Biology 2, School of Pharmacy, University of Granada, 18011 Granada, Spain.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101534003 Publication Model: Electronic Cited Medium: Print ISSN: 1999-4923 (Print) Linking ISSN: 19994923 NLM ISO Abbreviation: Pharmaceutics Subsets: PubMed not MEDLINE